IBDEI116 ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,18479,1,3,0)
 ;;=3
 ;;^UTILITY(U,$J,358.3,18479,1,5,0)
 ;;=5
 ;;^UTILITY(U,$J,358.3,18480,0)
 ;;=459.10^^121^1169^28
 ;;^UTILITY(U,$J,358.3,18480,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18480,1,3,0)
 ;;=3^459.10
 ;;^UTILITY(U,$J,358.3,18480,1,5,0)
 ;;=5^Post Phlebotic Syndrome
 ;;^UTILITY(U,$J,358.3,18480,2)
 ;;=Post Phlebotic Syndrome^328597
 ;;^UTILITY(U,$J,358.3,18481,0)
 ;;=719.7^^121^1169^18
 ;;^UTILITY(U,$J,358.3,18481,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18481,1,3,0)
 ;;=3^719.7
 ;;^UTILITY(U,$J,358.3,18481,1,5,0)
 ;;=5^Difficulty In Walking
 ;;^UTILITY(U,$J,358.3,18481,2)
 ;;=^329945
 ;;^UTILITY(U,$J,358.3,18482,0)
 ;;=453.40^^121^1169^5
 ;;^UTILITY(U,$J,358.3,18482,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18482,1,3,0)
 ;;=3^453.40
 ;;^UTILITY(U,$J,358.3,18482,1,5,0)
 ;;=5^Deep vein thrombosis lower extremity
 ;;^UTILITY(U,$J,358.3,18482,2)
 ;;=^338554
 ;;^UTILITY(U,$J,358.3,18483,0)
 ;;=357.2^^121^1169^17
 ;;^UTILITY(U,$J,358.3,18483,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18483,1,3,0)
 ;;=3^357.2
 ;;^UTILITY(U,$J,358.3,18483,1,5,0)
 ;;=5^Diabetic Polyneuropathy
 ;;^UTILITY(U,$J,358.3,18483,2)
 ;;=^96321
 ;;^UTILITY(U,$J,358.3,18484,0)
 ;;=692.9^^121^1170^1
 ;;^UTILITY(U,$J,358.3,18484,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18484,1,3,0)
 ;;=3^692.9
 ;;^UTILITY(U,$J,358.3,18484,1,5,0)
 ;;=5^Eczema
 ;;^UTILITY(U,$J,358.3,18484,2)
 ;;=^27800
 ;;^UTILITY(U,$J,358.3,18485,0)
 ;;=691.8^^121^1170^2
 ;;^UTILITY(U,$J,358.3,18485,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18485,1,3,0)
 ;;=3^691.8
 ;;^UTILITY(U,$J,358.3,18485,1,5,0)
 ;;=5^Eczema, allergic
 ;;^UTILITY(U,$J,358.3,18485,2)
 ;;=^87342
 ;;^UTILITY(U,$J,358.3,18486,0)
 ;;=782.3^^121^1170^3
 ;;^UTILITY(U,$J,358.3,18486,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18486,1,3,0)
 ;;=3^782.3
 ;;^UTILITY(U,$J,358.3,18486,1,5,0)
 ;;=5^Edema (any site)
 ;;^UTILITY(U,$J,358.3,18486,2)
 ;;=^38340
 ;;^UTILITY(U,$J,358.3,18487,0)
 ;;=726.70^^121^1170^4
 ;;^UTILITY(U,$J,358.3,18487,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18487,1,3,0)
 ;;=3^726.70
 ;;^UTILITY(U,$J,358.3,18487,1,5,0)
 ;;=5^Enthesopathy of ankle & tarsus, unspecified
 ;;^UTILITY(U,$J,358.3,18487,2)
 ;;=^272548
 ;;^UTILITY(U,$J,358.3,18488,0)
 ;;=736.72^^121^1170^5
 ;;^UTILITY(U,$J,358.3,18488,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18488,1,3,0)
 ;;=3^736.72
 ;;^UTILITY(U,$J,358.3,18488,1,5,0)
 ;;=5^Equinus deformity of foot, acquired
 ;;^UTILITY(U,$J,358.3,18488,2)
 ;;=^272744
 ;;^UTILITY(U,$J,358.3,18489,0)
 ;;=726.91^^121^1170^6
 ;;^UTILITY(U,$J,358.3,18489,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18489,1,3,0)
 ;;=3^726.91
 ;;^UTILITY(U,$J,358.3,18489,1,5,0)
 ;;=5^Exostosis of unspecified site
 ;;^UTILITY(U,$J,358.3,18489,2)
 ;;=^43688
 ;;^UTILITY(U,$J,358.3,18490,0)
 ;;=728.71^^121^1171^1
 ;;^UTILITY(U,$J,358.3,18490,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18490,1,3,0)
 ;;=3^728.71
 ;;^UTILITY(U,$J,358.3,18490,1,5,0)
 ;;=5^Fascite, Plantar
 ;;^UTILITY(U,$J,358.3,18490,2)
 ;;=^272598
 ;;^UTILITY(U,$J,358.3,18491,0)
 ;;=729.1^^121^1171^2
 ;;^UTILITY(U,$J,358.3,18491,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18491,1,3,0)
 ;;=3^729.1
 ;;^UTILITY(U,$J,358.3,18491,1,5,0)
 ;;=5^Fibromyalgia
 ;;^UTILITY(U,$J,358.3,18491,2)
 ;;=^80160
 ;;^UTILITY(U,$J,358.3,18492,0)
 ;;=709.8^^121^1171^3
 ;;^UTILITY(U,$J,358.3,18492,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18492,1,3,0)
 ;;=3^709.8
 ;;^UTILITY(U,$J,358.3,18492,1,5,0)
 ;;=5^Fissured skin
 ;;^UTILITY(U,$J,358.3,18492,2)
 ;;=^88026
 ;;^UTILITY(U,$J,358.3,18493,0)
 ;;=V53.7^^121^1171^4
